Ezra Cohen to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Ezra Cohen has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.175
-
Cabozantinib for the treatment of advanced medullary thyroid cancer. Adv Ther. 2012 Nov; 29(11):925-34.
Score: 0.100
-
ONYX-015. Onyx Pharmaceuticals. Curr Opin Investig Drugs. 2001 Dec; 2(12):1770-5.
Score: 0.047
-
Pharmacokinetics of single-agent axitinib across multiple solid tumor types. Cancer Chemother Pharmacol. 2014 Dec; 74(6):1279-89.
Score: 0.029